TMED8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63558055987778E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.99840144432528E-15 |
Normal-vs-Stage2 |
1.80558999999247E-05 |
Normal-vs-Stage3 |
6.78510000406973E-08 |
Normal-vs-Stage4 |
1.94790000018763E-07 |
Stage1-vs-Stage2 |
5.449800E-01 |
Stage1-vs-Stage3 |
8.512800E-01 |
Stage1-vs-Stage4 |
6.898600E-01 |
Stage2-vs-Stage3 |
7.241800E-01 |
Stage2-vs-Stage4 |
4.779600E-01 |
Stage3-vs-Stage4 |
6.499200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62880819942757E-12 |
Normal-vs-AfricanAmerican |
2.26959562255047E-11 |
Normal-vs-Asian |
3.96049999999981E-05 |
Caucasian-vs-AfricanAmerican |
7.239400E-01 |
Caucasian-vs-Asian |
7.938200E-01 |
AfricanAmerican-vs-Asian |
7.417200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.22690000048387E-07 |
Male-vs-Female |
4.056100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.45450001937309E-09 |
Normal-vs-Extreme_Weight |
1.62536650805123E-12 |
Normal-vs-Obese |
3.72319952646194E-10 |
Normal-vs-Extreme_Obese |
1.0523000004703E-07 |
Normal_Weight-vs-Extreme_Weight |
2.781200E-01 |
Normal_Weight-vs-Obese |
5.890200E-01 |
Normal_Weight-vs-Extreme_Obese |
5.711800E-01 |
Extreme_Weight-vs-Obese |
4.884300E-02 |
Extreme_Weight-vs-Extreme_Obese |
9.974200E-01 |
Obese-vs-Extreme_Obese |
3.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.221800E-04 |
Normal-vs-Age(41-60Yrs) |
2.27784457962343E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
1.31920000479013E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.656800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.482000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.288000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.583980E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.121800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.633400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.64357416565508E-12 |
Normal-VS-Type2 PRCC |
1.63280500231622E-12 |
Normal-VS-KIRP CIMP |
1.010450E-02 |
Normal-VS-Unclassified PRCC |
1.61660000053132E-07 |
Type1 PRCC-VS-Type2 PRCC |
1.434440E-01 |
Type1 PRCC-VS-KIRP CIMP |
9.500800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
8.509800E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.404200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.007600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
9.752800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.55031584528842E-15 |
Normal-vs-N1 |
2.15169999999709E-05 |
Normal-vs-N2 |
1.03789999994497E-06 |
N0-vs-N1 |
2.864000E-01 |
N0-vs-N2 |
3.518800E-01 |
N1-vs-N2 |
2.777600E-01 |
|
|